Results 141 to 150 of about 1,347 (192)
Hypotrichosis 14: novel variants of the LSS gene in five Chinese families and insights from literature review. [PDF]
Zhang Y +7 more
europepmc +1 more source
Novel Compound Heterozygous Variants of <i>DSP</i> Causing Skin Fragility-Woolly Hair Syndrome: A Rare Case Report and Literature Review. [PDF]
Yang M, Zhang G, Luo S.
europepmc +1 more source
Naegeli-Franceschetti-Jadassohn syndrome: a systematic review of case studies. [PDF]
Shah HH +13 more
europepmc +1 more source
Severe palmoplantar keratoderma: a cutaneous complication from sub-optimally controlled type 2 diabetes. [PDF]
Iqbal F, Phan K, Cheung WN.
europepmc +1 more source
The use of upadacitinib for refractory pityriasis rubra pilaris: A case report. [PDF]
Batchelor T, Conner CD.
europepmc +1 more source
openaire
Capecitabine was developed as a prodrug of 5-fluorouracil (FU), with the goal of improving tolerability and intratumour drug concentrations through tumour-specific conversion to the active drug against numerous types of neoplasms. The most frequent adverse cutaneous reaction associated with capecitabine is hand foot syndrome (HFS), presented with ...
J E, Do, Y C, Kim
openaire +3 more sources
Diffuse palmoplantar keratoderma with deafness.
Two brothers with diffuse palmoplantar keratoderma (Thost-Unna type) also were deaf. Of the 38 members of the patients' family, five had a similar disorder and ten had only hearing loss. The mode of inheritance of the dermatosis is regarded as autosomal dominant and is diagnostically distinguished from the other dermatoses associated with the ...
A, Hatamochi +4 more
core +4 more sources
Autosomal dominant diffuse non-epidermolytic palmoplantar keratoderma (NEPPK) is a clinically and genetically heterogeneous disorder, one form of which is associated with a whitish spongy appearance upon immersion in water (MIM 600231). Using linkage data in combination with whole-exome sequencing in families with NEPPK, heterozygosity for 5 different ...
Abdul-Wahab, A +7 more
openaire +4 more sources

